CoChat

Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1

Open access
Fang, Ling, Du, William W., Lyu, Juanjuan, Dong, Jun, Zhang, Chao, Yang, Weining, He, Alina, Kwok, Yat Sze Sheila, Ma, Jian, Wu, Nan, Li, Feiya, Awan, Faryal Mehwish, He, Chengyan, Yang, Bing L., Peng, Chun, MacKay, Helen J., Yee, Albert J., Yang, Burton B. · 2018 · Cell Death & Differentiation
Cited by 139

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

TP53 mutations occur in many different types of cancers that produce mutant p53 proteins. The mutant p53 proteins have lost wild-type p53 activity and gained new functions that contribute to malignant tumor progression. Different p53 mutations create distinct profiles in loss of wild-type p53 activity and gain of functions. Targeting the consequences generated by the great number of p53 mutations would be extremely complex. Therefore, in this study we used a workaround and took advantage of the fact that mutant p53 cannot bind H2AX. Using this, we developed a new approach to repress the acquisition of mutant p53 functions. We show here that the delivery of a circular RNA circ-Ccnb1 inhibited the function of three p53 mutations. By microarray analysis and real-time PCR, we detected decreased circ-Ccnb1 expression levels in patients bearing breast carcinoma. Ectopic delivery of circ-Ccnb1 inhibited tumor growth and extended mouse viability. Using proteomics, we found that circ-Ccnb1 precipitated p53 in p53 wild-type cells, but instead precipitated Bclaf1 in p53 mutant cells. Further experiments showed that H2AX serves as a bridge, linking the interaction of circ-Ccnb1 and wild-type p53, thus allowing Bclaf1 to bind Bcl2 resulting in cell survival. In the p53 mutant cells, circ-Ccnb1 formed a complex with H2AX and Bclaf1, resulting in the induction of cell death. We found that this occurred in three p53 mutations. These results shed light on the possible development of new approaches to inhibit the malignancy of p53 mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41418-018-0115-6

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 139

Metadata

Authors
Fang, L., Du, W. W., Lyu, J., Dong, J., Zhang, C., Yang, W., He, A., Kwok, Y. S. S., Ma, J., Wu, N., Li, F., Awan, F. M., He, C., Yang, B. L., Peng, C., MacKay, H. J., Yee, A. J., & Yang, B. B.
Venue
Cell Death & Differentiation
Published
2018-05-23
Volume
25
Issue
12
Pages
2195-2208
ISSN
  • 1350-9047 (ISSN-L)
  • 1476-5403
OpenAlex
W2804601578
Cited by
139
References
15
FWCI
6.12
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1. https://app.cochat.ai/papers/10.1038/s41418-018-0115-6
The paper
Fang, L., Du, W. W., Lyu, J., Dong, J., Zhang, C., Yang, W., He, A., Kwok, Y. S. S., Ma, J., Wu, N., Li, F., Awan, F. M., He, C., Yang, B. L., Peng, C., MacKay, H. J., Yee, A. J., & Yang, B. B. (2018). Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1. Cell Death & Differentiation. https://doi.org/10.1038/s41418-018-0115-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.